The Lung Cancer Innovation Challenge
Challenge Description
Identify, implement, and scale solutions that can reduce the length of time between diagnosis and treatment for lung cancer patients, and enable improved treatment outcomes, especially for priority patient groups such as rural and lower socioeconomic populations in Ontario.
Who Should Participate?
Ontario-based:
- Healthcare workers
- Non-profits
- Researchers
- Private sector organizations
- Public sector institutions
- General public
Opportunity
- 1 grand prize of $100,000
- 1 runner-up prize of $50,000
- Post-challenge: scaling and adoption-oriented activities
What’s Happening Now?
- The grand prize winner and runner-up have been announced. Learn about their solutions here.
- Watch the recordings from our launch event, informational webinar, and finalist showcase.
Overview
Of the four most common cancers, lung cancer has the lowest survival rate, regardless of stage at diagnosis. The five-year relative survival ratio is 60.8 percent when diagnosed at Stage 1, and only 3.3 percent when diagnosed at Stage 4 (2010–2013). It is estimated that 29,800 new lung cancer cases will be diagnosed in 2020 across Canada, with almost 40% of those cases residing in Ontario alone. Furthermore, it is estimated that 21,200 Canadians are expected to die from lung cancer in 2020, which is higher than colorectal, breast, and prostate cancer combined (19,000 in 2020). When combined with the fact that the majority of lung cancer cases are diagnosed at Stage 4, it becomes clear that initial access to primary care, and the time between diagnosis and treatment is critical in determining patient outcomes. The ability for lung cancer patients to receive the proper treatment at the right time is dependent upon a number of different factors that touch on the patient, their circle of care, and the broader health system.
The current COVID-19 pandemic poses further challenges to lung cancer patients, but also provides an opportunity to support the COVID-19 response through the identification and strengthening of overlapping areas that can further increase the resilience of our healthcare system.
The Lung Cancer Innovation Challenge is asking Ontario-based innovators to identify, implement, and scale solutions that can reduce the length of time between diagnosis and treatment for lung cancer patients, and enable improved treatment outcomes especially for priority patient groups such as rural and lower socioeconomic populations in Ontario.
Sign up for our mailing list to receive updates about this Challenge. E-mail challenges@marsdd.com with any questions.
About Merck
For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada
Challenge Structure
This challenge is aimed at identifying, implementing, and scaling solutions that can enhance a lung cancer patient’s journey by reducing the length of time between diagnosis and treatment for lung cancer patients, and enable improved treatment outcomes, especially for priority patient groups such as rural and lower socioeconomic populations in Ontario.
How to enter
Innovators must complete the following steps to enter this challenge:
- Create a profile on https://challenges.marsdd.com/
- Read the Challenge Rules
- Click “Accept Challenge” on the Lung Cancer Innovation Challenge webpage
- Ensure you meet the eligibility requirements as outlined in the Challenge Rules and on the Lung Cancer Innovation Challenge webpage
- Complete the Submission Form, following word limits where indicated, and save in PDF format with your team/applicant name and date listed in the file name (e.g. Team-Lung-Cancer_Mar252021_ Submission-Form)
- Click “Submit Application” on the Lung Cancer Innovation Challenge webpage and upload your saved Submission Form
- Ensure you submit by March 25, 2021 11:59 p.m. ET
Finalist showcase
Up to five finalists will be invited to present their solutions during our unique Virtual Finalist Showcase event on April 22, 2021. This showcase will be broadcast across Canada.
Prizes
The Challenge grand prize winner and runner-up prize winner will be selected and announced after the Virtual Finalist Showcase and no later than April 28, 2021. The grand prize winner will be awarded $100,000 and the runner-up prize winner will be awarded $50,000. Please see the Challenge Rules for further information about the Challenge prize.
Timeline
Challenge launch (20/01/2021)
The challenge is officially open!
Informational webinar (17/02/2021)
Learn more about how to participate.
Missed the webinar? Watch the recording in the FAQ section.
Submission deadline (25/03/2021)
Submit your solution by 11:59 p.m. EST
Finalist showcase (22/04/2021)
Learn about the top solutions at this unique event.
Winners announcement (28/04/2021)
Find out who the winners are
Required for Submission
Additional Resources
FAQ
The grand prize winner and runner-up have been announced! Read more about the teams and their solutions here.
You can find a list of the judging criteria here.
As described in the Challenge Rules, you may only enter the Challenge if at the time of entry, you (and your team members, as applicable) meet all of the below requirements (this list is not exhaustive – please refer to the Challenge Rules for full entry requirements and conditions:
- You are an individual and, at the time of entry: (a) you are a legal resident of Ontario, and (b) you are at least the age of majority in the province.
OR
- You are a group of individuals entering the Challenge as a team and: (a) each of you, at the time of entry, is (i) a legal resident of Ontario, and (ii) at least the age of majority in the province; and (b) you designate one (1) member of your team as your eligible Authorized Representative to enter the Challenge.
OR
- You are a company or organization which: (a) at the time of entry, is either (i) incorporated under the laws of Ontario; or (ii) operating in the province of Ontario; and (b) you designate one (1) eligible Authorized Representative to enter the Challenge.
AND
- At the time of entry and throughout the Challenge Period, you are not (or you, whether entering the contest individually or as part of a team, are not directly working for, (as a part-time or fulltime employee, or on a contract basis)) a pharmaceutical company competing with Merck Canada Inc., as determined by the Merck Canada Inc. and MaRS Discovery District in their sole and absolute discretion.
AND
- You are not an employee, an immediate family member (i.e., spouse, sibling, children, spouses’ parents, and the spouses of any of those individuals) and household members (related or not) of: MaRS, Merck Canada Inc., and each of their respective representatives, agents, parent companies, subsidiaries, affiliates, judges, advertising and promotional agencies and anyone otherwise connected with the Challenge.
AND
- The proposed technology, invention or process is a lawful, original and novel innovation.
AND
- The technology, invention or process is your (and your team members’, as applicable) own work and you (and your team members’, as applicable) have the sole right to submit the innovation to the Challenge.
AND
- The solution is not at the ideation stage in maturity. The solution is at the discovery, working prototype, validation, or established stage in maturity.
The entrant(s) (individual, team, company or organization, as applicable) will retain all intellectual property rights to their proposed technology, invention or process. For more details on intellectual property rights, please see the Challenge Rules.
No. All submissions are kept private and information is only shared with MaRS Discovery District, Merck Canada, and the judging panel. No details are shared with other entrants.
Innovators must complete the following steps to enter this challenge:
- Create a profile on https://challenges.marsdd.com/
- Read the Challenge Rules
- Click “Accept Challenge” on the Lung Cancer Innovation Challenge webpage
- Ensure you meet the eligibility requirements as outlined in the Challenge Rules and on the Lung Cancer Innovation Challenge webpage
- Complete the Submission Form, following word limits where indicated, and save in PDF format with your team/applicant name and date listed in the file name (e.g. Team-Lung-Cancer_Mar252021_ Submission-Form)
- Click “Submit Application” on the Lung Cancer Innovation Challenge webpage and upload your saved Submission Form
- Ensure you submit by March 25, 2021 11:59 p.m. ET
If you have any further questions, please contact the challenge coordinator at: challenges@marsdd.com.